Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline–triazine derivatives

References

• UNAIDS 2011 World AIDS Day report. Available from: http://www.unaids.org. [last accessed 30 Oct 2012]
   Google Scholar
• Ragno R, Frasca S, Manetti F, et al. HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies. J Med Chem 2004;48:200–12
   Google Scholar
• Hirschel B, Francioli P. Progress and problems in the fight against AIDS. N Engl J Med 1998;338:906–8
   PubMed Web of Science ®Google Scholar
• De Clercq E. New developments in anti-HIV chemotherapy. Curr Med Chem 2001;8:1543–72
   PubMed Web of Science ®Google Scholar
• Das K, Clark AD, Lewi PJ, et al. Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. J Med Chem 2004;47:2550–60
   PubMed Web of Science ®Google Scholar
• Muregi FW, Ishih A. Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design. Drug Develop Res 2010;71:20–32
   PubMed Web of Science ®Google Scholar
• Zhou C, Min J, Liu Z, et al. Synthesis and biological evaluation of novel 1,3,5-triazine derivatives as antimicrobial agents. Bioorg Med Chem Lett 2008;18:1308–11
   PubMed Web of Science ®Google Scholar
• Srinivas K, Srinivas U, Bhanuprakash K, et al. Synthesis and antibacterial activity of various substituted s-triazines. Eur J Med Chem 2006;41:1240–6
   PubMed Web of Science ®Google Scholar
• Modh RP, Patel AC, Mahajan DH, et al. Synthesis and evaluation of novel 4-substituted styryl quinazolines as potential antimicrobial agents. Arch Pharm 2012; 345:964--72
   PubMedGoogle Scholar
• Kaswala PB, Chikhalia KH, Shah NK, et al. Design, synthesis and antimicrobial evaluation of s-triazinyl urea and thiourea derivatives. Arkivoc 2009;11:326–35
   Web of Science ®Google Scholar
• Machakanur SS, Patil BR, Pathan AH, et al. Synthesis, antimicrobial and antimycobacterial evaluation of star shaped hydrazones derived from 1,3,5-triazine. Der Pharma Chemica 2012;4:600–7
   Google Scholar
• Menicagli R, Samaritani S, Signore G, et al. In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: new molecules in anticancer research. J Med Chem 2004;47:4649–52
   PubMed Web of Science ®Google Scholar
• Garaj V, Puccetti L, Fasolis G, et al. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Bioorg Med Chem Lett 2005;15:3102–8
   PubMed Web of Science ®Google Scholar
• Melato S, Prosperi D, Coghi P, et al. A combinatorial approach to 2,4,6-trisubstituted triazines with potent antimalarial activity: combining conventional synthesis and microwave-assistance. ChemMedChem 2008;3:873–6
   PubMed Web of Science ®Google Scholar
• Xiong YZ, Chen FE, Balzarini J, et al. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity. Eur J Med Chem 2008;43:1230–6
   PubMed Web of Science ®Google Scholar
• Bartroli J, Turmo E, Algueró M, et al. New azole antifungals. 3. synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones1,2. J Med Chem 1998;41:1869–82
   PubMed Web of Science ®Google Scholar
• El-Sharief A, Ammar Y, Zahran M, et al. Aminoacids in the synthesis of heterocyclic systems: the synthesis of triazinoquinazolinones, triazepinoquinazolinones and triazocinoquinazolinones of potential biological interest. Molecules 2001;6:267–78
   Google Scholar
• Modh RP, Patel AC, Chikhalia KH. Design, synthesis biological evaluation of some novel quinazolinone scaffolds. Med Chem 2012;8:182–92
   PubMedGoogle Scholar
• Purohit DM, Bhuva VR, Shah VH. Synthesis of 5-arylaminosulpho-N-acetylanthranilic acid, 6-arylaminosulpho-2-methyl-3-amino/3-N-chloroacetamido/3-N-arylaminoacetamido-4-(3H)-quinazolones as potential anti-HIV, anticancer and antimicrobial agents. Chem Indian J 2003;1:233–45
   Google Scholar
• Wang Z, Wang M, Yao X, et al. Design, synthesis and antiviral activity of novel quinazolinones. Eur J Med Chem 2012;53:275–82
   PubMed Web of Science ®Google Scholar
• Murav'eva KM, Arkhangel'skaya NV, Shchukina MN, et al. Synthesis and tuberculostatic activity of aminoquinazoline derivatives. Pharm Chem J 1971;5:339–41
   Google Scholar
• Barker (ZENECA Limited) AJ, inventor; Quinazoline derivatives and their use as anti-cancer agents, European patent EP 0635498; 1995
   Google Scholar
• Laddha SS, Bhatnagar SP. A new therapeutic approach in Parkinson’s disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents. Bioorg Med Chem 2009;17:6796–802
   PubMed Web of Science ®Google Scholar
• Aziza MA, Ibrahim MK, El-Helpy AG. Part II. Synthesis of novel-2-styryl-3-benzylidenimino-4(3H)-quinazolone derivatives of expected anticonvulsant activity. Al-Azhar J Pharm Sci 1994;14:193–201
   Google Scholar
• Jatav V, Mishra P, Kashaw S, Stables JP. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur J Med Chem 2008;43:1945–54
   PubMed Web of Science ®Google Scholar
• Kurogi Y, Inoue Y, Tsutsumi K, et al. Synthesis and hypolipidemic activities of novel 2-[4-[(diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones. J Med Chem 1996;39:1433–7
   PubMed Web of Science ®Google Scholar
• Terashima K, Shimamura H, Kawase A, et al. Studies on antiulcer agents. IV: antiulcer effects of 2-benzylthio-5, 6, 7, 8-tetrahydro-4 (3H)-quinazolinones and related compounds. Chem Pharm Bull 1995;43:2021–3
   PubMed Web of Science ®Google Scholar
• Alagarsamy V, Raja Solomon V, Dhanabal K. Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents. Bioorg Med Chem 2007;15:235–41
   PubMed Web of Science ®Google Scholar
• Nawrocka W, Zimecki M. Syntheses of Novel 3-Amino-2(1H)-thioxo-4(3H)-quinazolinones and evaluation of their immunotropic activity. Part III. Arch Pharm 1997;330:399–405
   PubMed Web of Science ®Google Scholar
• Upadhayaya RS, Vandavasi JK, Kardile RA, et al. Novel quinoline and naphthalene derivatives as potent antimycobacterial agents. Eur J Med Chem 2010;45:1854–67
   PubMed Web of Science ®Google Scholar
• Al-Turkistani AA, Al-Deeb OA, El-Brollosy NR,El-Emam AA. Synthesis and antimicrobial activity of some novel 5-alkyl-6-substituted uracils and related derivatives. Molecules 2011;16:4764–74
   PubMedGoogle Scholar
• Ananda Kumar C, Vinaya K, Narendra Sharath Chandra J, et al. Synthesis and antimicrobial studies of novel 1-benzhydryl-piperazine sulfonamide and carboxamide derivatives. J Enzyme Inhib Med Chem 2008;23:462–9
   PubMed Web of Science ®Google Scholar
• Upadhayaya RS, Sinha N, Jain S, et al. Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-{2-[4-aryl-piperazin-1-yl]-ethyl}-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol. Bioorg Med Chem 2004;12:2225–38
   PubMed Web of Science ®Google Scholar
• Banerjee D, Yogeeswari P, Bhat P, et al. Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection. Eur J Med Chem 2011;46:106–21
   PubMed Web of Science ®Google Scholar
• Singh KK, Joshi SC, Mathela CS. Synthesis and in vitro antibacterial activity of N-alkyl and N-aryl piperazine derivatives. Indian J Chem B 2011;50:196
   Google Scholar
• Kerns RJ, Rybak MJ, Kaatz GW, et al. Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus. Bioorg Med Chem Lett 2003;13:2109–12
   PubMed Web of Science ®Google Scholar
• Patel RV, Kumari P, Rajani DP, et al. Antimicrobial, anti-TB, anticancer and anti-HIV evaluation of new s-triazine-based heterocycles. Future Med Chem 2012;4:1053–65
   PubMedGoogle Scholar
• Patel RB, Desai KR, Chikhalia KH. Synthesis and studies of novel homoveratryl based thiohydantoins as antibacterial as well as anti-HIV agents. Indian J Chem B 2006;45B:1716
   Google Scholar
• Patel RB, Chikhalia KH, Pannecouque C, Clercq E. Synthesis of novel PETT analogues: 3, 4-dimethoxy phenyl ethyl 1, 3, 5-triazinyl thiourea derivatives and their antibacterial and anti-HIV studies. J Braz Chem Soc 2007;18:312–21
   Web of Science ®Google Scholar
• Patel RB, Chikhalia KH. Synthesis of heterocyclic and non-heterocyclic entities as antibacterial and anti-HIV agents. Indian J Chem B 2006;45B:1871
   Google Scholar
• Mahajan DH, Pannecouque C, De Clercq E, Chikhalia KH. Synthesis and studies of new 2-(coumarin-4-yloxy)-4, 6-(substituted)-s-triazine derivatives as potential anti-HIV agents. Arch Pharm 2009;342:281–90
   PubMed Web of Science ®Google Scholar
• Desai SD, Desai KR, Chikhalia KH, et al. Synthesis of a novel class of some 1, 3, 5-triazine derivatives and their anti-HIV activity. Int J Drug Des Dis 2011;2:361–8
   Google Scholar
• Chen X, Zhan P, Liu X, et al. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem 2012;20:3856–64
   PubMed Web of Science ®Google Scholar
• Mallal S, Nolan D, Witt C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002;359:727–32
   PubMed Web of Science ®Google Scholar
• Mutlib A, Chen H, Shockcor J, et al. Characterization of novel glutathione adducts of a non-nucleoside reverse transcriptase inhibitor, (s)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-3,4-dihydro-2(1h)-quinazolinone (dpc 961), in rats. possible formation of an oxirene metabolic intermediate from a disubstituted alkyne. Chem Res Toxicol 2000;13:775–84
   PubMed Web of Science ®Google Scholar
• Hawkey P, Lewis DA. Medical bacteriology: a practical approach. Oxford, UK: Oxford University Press; 2004
   Google Scholar
• Baba M, Snoeck R, Pauwels R, De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, human immunodeficiency virus. Antimicrob Agents Chemother 1988;32:1742–5
   PubMed Web of Science ®Google Scholar
• Pannecouque C, Daelemans D, De Clercq E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later. Nat Protoc 2008;3:427–34
   PubMed Web of Science ®Google Scholar
• Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497–500
   PubMed Web of Science ®Google Scholar
• Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868–71
   PubMed Web of Science ®Google Scholar
• Miyoshi I, Taguchi H, Kubonishi I, et al. Type C virus-producing cell lines derived from adult T cell leukemia. Gann Monogr 1982;28:219–28
   Google Scholar